menu
    • menu

    Company profile for Model Medicines

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.Led by the best and brightest in chemistry, informatics, AI and machine learning, our Model Medicines CHEMprint™ AI/ML drug discovery platform empowers our drug discoverers and developers to create a growing pipeline of novel m...
    Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.Led by the best and brightest in chemistry, informatics, AI and machine learning, our Model Medicines CHEMprintâ„¢ AI/ML drug discovery platform empowers our drug discoverers and developers to create a growing pipeline of novel medicines for untreated or poorly treated diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Model MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1268 Prospect Street, La Jolla, CA 92037
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.modelmedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/modelmedicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/modelmedicines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AI drug discoverer's antiviral reduces COVID in mouse lungs
    AI drug discoverer's antiviral reduces COVID in mouse lungs

    21 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/ai-drug-discoverer-thumbs-nose-rna-viruses-new-broadly-effective-antiviral

    FIERCE BIOTECH
    21 Jan 2025
    Share Share
    Model Medicines Unveils AI Drug Discovery Advances
    Model Medicines Unveils AI Drug Discovery Advances

    09 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/model-medicines-unveils-groundbreaking-ai-drug-discovery-advances-in-new-chemistry-and-new-biology-with-two-new-preprint-papers-302111389.html

    PR NEWSWIRE
    09 Apr 2024
    Share Share
    Model Discovers NCE Library, Achieving 66.7% Hit Rate Using AI Platform
    Model Discovers NCE Library, Achieving 66.7% Hit Rate Using AI Platform

    20 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/model-medicines-discovers-new-pan-antiviral-chemical-entity-nce-library-achieving-unprecedented-66-7-hit-rate-using-proprietary-ai-platform-302093850.html

    PR NEWSWIRE
    20 Mar 2024
    Share Share
    Model Medicines Announces Launch of Oncology Programs
    Model Medicines Announces Launch of Oncology Programs

    04 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/model-medicines-announces-launch-of-oncology-programs-with-multiple-ai-discovered-compounds-demonstrating-drug-like-activity-for-two-high-value-difficult-to-drug-oncogenic-and-epigenetic-targets-301640018.html

    PRNEWSWIRE
    04 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search